These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36270831)

  • 61. Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experience.
    Hadoux J; Rey A; Duvillard P; Lhommé C; Balleyguier C; Haie-Meder C; Morice P; Tazi Y; Leary A; Larue C; Pautier P
    Int J Gynecol Cancer; 2015 Feb; 25(2):296-302. PubMed ID: 25581897
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma.
    Rauh-Hain JA; Hinchcliff EM; Oduyebo T; Worley MJ; Andrade CA; Schorge JO; George S; Muto MG; del Carmen MG
    Int J Gynecol Cancer; 2014 Oct; 24(8):1434-40. PubMed ID: 25248114
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Potential Prognostic and Therapeutic Implications of Prolactin Receptor and Growth Hormone-releasing Hormone Receptor Expression in Uterine Leiomyosarcomas.
    Jones TE; La HS; Upadhyay-Baskota S; Bhargava R; Jones MW
    Int J Gynecol Pathol; 2022 Nov; 41(6):566-572. PubMed ID: 34856572
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients.
    Tirumani SH; Deaver P; Shinagare AB; Tirumani H; Hornick JL; George S; Ramaiya NH
    J Gynecol Oncol; 2014 Oct; 25(4):306-12. PubMed ID: 25142630
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.
    Oduyebo T; Rauh-Hain AJ; Meserve EE; Seidman MA; Hinchcliff E; George S; Quade B; Nucci MR; Del Carmen MG; Muto MG
    Gynecol Oncol; 2014 Feb; 132(2):360-5. PubMed ID: 24296345
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005).
    Hensley ML; Wathen JK; Maki RG; Araujo DM; Sutton G; Priebat DA; George S; Soslow RA; Baker LH
    Cancer; 2013 Apr; 119(8):1555-61. PubMed ID: 23335221
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.
    Akhan SE; Yavuz E; Tecer A; Iyibozkurt CA; Topuz S; Tuzlali S; Bengisu E; Berkman S
    Gynecol Oncol; 2005 Oct; 99(1):36-42. PubMed ID: 15992918
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
    Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Uterine leiomyosarcoma: A review of the literature and update on management options.
    Roberts ME; Aynardi JT; Chu CS
    Gynecol Oncol; 2018 Dec; 151(3):562-572. PubMed ID: 30244960
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of adjuvant treatment on oncologic outcomes in patients with stage I leiomyosarcoma of the uterus.
    Boyraz G; Başaran D; Salman MC; Özgül N; Yüce K
    Turk J Med Sci; 2017 Jun; 47(3):841-846. PubMed ID: 28618731
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Role of Endometrial Biopsy in the Preoperative Detection of Uterine Leiomyosarcoma.
    Hinchcliff EM; Esselen KM; Watkins JC; Oduyebo T; Rauh-Hain JA; Del Carmen MG; Quade BJ; Muto MG
    J Minim Invasive Gynecol; 2016; 23(4):567-72. PubMed ID: 26851414
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A nomogram for predicting overall survival in patients with uterine leiomyosarcoma: a SEER population-based study.
    Lu YJ; Wang H; Fang LY; Wang WJ; Song W; Wang Y; Huang YQ; Din ZL
    Future Oncol; 2020 Apr; 16(10):573-584. PubMed ID: 32141309
    [No Abstract]   [Full Text] [Related]  

  • 73. Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?
    Ricci S; Giuntoli RL; Eisenhauer E; Lopez MA; Krill L; Tanner EJ; Gehrig PA; Havrilesky LJ; Secord AA; Levinson K; Frasure H; Celano P; Fader AN
    Gynecol Oncol; 2013 Dec; 131(3):629-33. PubMed ID: 24016408
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Uterine leiomyosarcoma metastatic to the sphenoid sinus: a case report and review of the literature.
    Sandruck J; Escobar P; Lurain J; Fishman D
    Gynecol Oncol; 2004 Feb; 92(2):701-4. PubMed ID: 14766270
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    J Cancer Res Clin Oncol; 2008 Dec; 134(12):1277-87. PubMed ID: 18506484
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors.
    Thanopoulou E; Thway K; Khabra K; Judson I
    Clin Sarcoma Res; 2014; 4():5. PubMed ID: 25018868
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The selected biomarker analysis in 5 types of uterine smooth muscle tumors.
    Zhang Q; Kanis MJ; Ubago J; Liu D; Scholtens DM; Strohl AE; Lurain JR; Shahabi S; Kong B; Wei JJ
    Hum Pathol; 2018 Jun; 76():17-27. PubMed ID: 29258902
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study.
    Hensley ML; Miller A; O'Malley DM; Mannel RS; Behbakht K; Bakkum-Gamez JN; Michael H
    J Clin Oncol; 2015 Apr; 33(10):1180-5. PubMed ID: 25713428
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma.
    Leitao MM; Brennan MF; Hensley M; Sonoda Y; Hummer A; Bhaskaran D; Venkatraman E; Alektiar K; Barakat RR
    Gynecol Oncol; 2002 Dec; 87(3):287-94. PubMed ID: 12468327
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Myxoid leiomyosarcoma of the uterus: a case report and review of the literature.
    Zhang L; Li Y; Qu Q; Wen K
    Eur J Gynaecol Oncol; 2016; 37(6):870-872. PubMed ID: 29943940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.